Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Adenosine A1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma japonicum | 5-hydroxytryptamine receptor 4, putative | Adenosine A1 receptor | 326 aa | 301 aa | 25.6 % |
Onchocerca volvulus | Adenosine A1 receptor | 326 aa | 326 aa | 20.2 % | |
Loa Loa (eye worm) | hypothetical protein | Adenosine A1 receptor | 326 aa | 296 aa | 22.6 % |
Onchocerca volvulus | Adenosine A1 receptor | 326 aa | 307 aa | 21.2 % | |
Onchocerca volvulus | Adenosine A1 receptor | 326 aa | 311 aa | 21.9 % | |
Schistosoma mansoni | opsin-like receptor | Adenosine A1 receptor | 326 aa | 312 aa | 22.1 % |
Schistosoma mansoni | peptide (allatostatin)-like receptor | Adenosine A1 receptor | 326 aa | 312 aa | 24.0 % |
Onchocerca volvulus | Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog | Adenosine A1 receptor | 326 aa | 286 aa | 22.7 % |
Schistosoma mansoni | opsin-like receptor | Adenosine A1 receptor | 326 aa | 315 aa | 23.8 % |
Echinococcus granulosus | allatostatin A receptor | Adenosine A1 receptor | 326 aa | 304 aa | 25.3 % |
Schistosoma mansoni | neuropeptide receptor | Adenosine A1 receptor | 326 aa | 277 aa | 23.8 % |
Echinococcus multilocularis | allatostatin A receptor | Adenosine A1 receptor | 326 aa | 306 aa | 26.1 % |
Schistosoma mansoni | neuropeptide receptor | Adenosine A1 receptor | 326 aa | 314 aa | 21.7 % |
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Adenosine A1 receptor | 326 aa | 318 aa | 22.3 % |
Loa Loa (eye worm) | neuropeptide F receptor | Adenosine A1 receptor | 326 aa | 316 aa | 19.3 % |
Brugia malayi | hypothetical protein | Adenosine A1 receptor | 326 aa | 311 aa | 21.9 % |
Schistosoma japonicum | ko:K04134 cholinergic receptor, invertebrate, putative | Adenosine A1 receptor | 326 aa | 331 aa | 25.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0639 | 0 | 0.5 |
Brugia malayi | Matrixin family protein | 0.1268 | 0.4963 | 1 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0639 | 0 | 0.5 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0755 | 0.092 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0755 | 0.092 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.1163 | 0.4136 | 1 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0755 | 0.092 | 0.1853 |
Wolbachia endosymbiont of Brugia malayi | extracellular metallopeptidase | 0.1257 | 0.488 | 0.5 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0755 | 0.092 | 0.5 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0755 | 0.092 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.1163 | 0.4136 | 0.8334 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0755 | 0.092 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.1268 | 0.4963 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.1163 | 0.4136 | 1 |
Mycobacterium ulcerans | hydrolase | 0.0639 | 0 | 0.5 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0755 | 0.092 | 0.1853 |
Leishmania major | carbonic anhydrase-like protein | 0.0755 | 0.092 | 0.5 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0755 | 0.092 | 0.1853 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0755 | 0.092 | 0.1853 |
Brugia malayi | Hemopexin family protein | 0.0743 | 0.0827 | 0.1666 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.1906 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.216 nM | Displacement of [3H]-CPX from Adenosine A1 receptor of bovine brain cerebral cortex membranes | ChEMBL. | 9484505 |
Ki (binding) | = 0.216 nM | Displacement of [3H]-CPX from Adenosine A1 receptor of bovine brain cerebral cortex membranes | ChEMBL. | 9484505 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.